GCP
MYOV

GSA Capital Partners’s Myovant Sciences Ltd. MYOV Stock Holding History

GSA Capital Partners’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,586
Closed -$289K – 1959
2021
Q4 		$289K Buy
18,586
+4,330
+30% +$82.7K 0.04% 960
2021
Q3 		$320K Buy
14,256
+3,204
+29% +$70.3K 0.03% 976
2021
Q2 		$252K Buy
+11,052
New +$233K 0.03% 1056
2021
Q1 		– Sell
-12,054
Closed -$333K – 1612
2020
Q4 		$333K Sell
12,054
-2,264
-16% -$44.1K 0.05% 682
2020
Q3 		$201K Buy
+14,318
New +$266K 0.03% 1011
2019
Q4 		– Sell
-25,685
Closed -$134K – 1822
2019
Q3 		$134K Buy
+25,685
New +$191K 0.02% 1246

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

GSA Capital Partners's MYOV Position: Q1 2022 in Review

GSA Capital Partners sold out of Myovant Sciences Ltd. (MYOV) in Q1 2022, closing a stake of 18,586 shares — an estimated $289K sold.

GSA Capital Partners first reported a position in MYOV in Q3 2019 and held it in 6 quarters. The position peaked at $333K in Q4 2020. 89 funds tracked by Wall St. Rank hold MYOV as of Q1 2022.

  • GSA Capital Partners reported no remaining Myovant Sciences Ltd. position as of Q1 2022 after selling out during the quarter.
  • GSA Capital Partners sold 18,586 Myovant Sciences Ltd. shares in Q1 2022, an estimated $289K.
  • GSA Capital Partners first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 6 quarters.
  • GSA Capital Partners's Myovant Sciences Ltd. position peaked at $333K in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2022.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.